Responses
Regular and Young Investigator Award Abstracts
Immunotherapy Toxicities
1232 PBMC humanized mouse model with clinical relevance in assessing the safety profile of 4–1BB agonist, urelumab, in 5 donors
Compose a Response to This Article
Other responses
No responses have been published for this article.
